NARA Discovery
Article Details
← Back to Search Results
Journal Article

TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer

Xinyi Shao; Dawei Yang; Liuqun Shan; Xueqin Yan; Di Xu; Lei Li; Yidan Sun; Qiang Yu; Honglei Zhou; Yongbin Ding; Jinhai Tang
Archives of Toxicology · Vol. 98, Issue 3 · pp. 865-881 · 2024
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalArchives of Toxicology
PublisherSpringer
Publication Date2024-03-01
Publication Year2024
Volume98
Issue3
Pages865-881
Document TypeJournal Article
Print ISSN0340-5761
eISSN1432-0738
DOI10.1007/s00204-023-03670-6

Access Information

NARA Access Coverage1930-01-01~Current
Journal Homepagehttps://www.springer.com/journal/204
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.